2m 2m 2m 2m 2m 2m 2m
Biogen (BIIB)
NASDAQ
$223.10+$3.22 (+1.46%)
Price as of Oct 02, 2026 7:46 PM EDT- $32.9BMarket Cap
- 37.53%1-Year Change
- Drug Manufacturers - GeneralIndustry
Biogen (BIIB)
$223.10+$3.22 (+1.46%)
BIIB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $219.88 | ||
Change | -$2.94 (-1.32%) | ||
Open | $222.98 | ||
High | $224.08 | ||
Low | $219.81 | ||
Previous Close | $222.82 | ||
Volume | 782,895 | ||
30-Day Average Volume | 1,055,785 | ||
1-Week Change | -3.39% | ||
1-Month Change | -1.25% | ||
1-Year Change | 37.53% | ||
3-Year Change | -13.04% | ||
5-Year Change | -22.56% | ||
Fundamentals | |||
Shares Outstanding | 147.8M | ||
Total Assets | $32.1B | ||
Market Cap | $32.9B | ||
Enterprise Value | $39.7B | ||
Period: QTR TTM FY | |||
Revenue | $1.9B | ||
Net Income | $97.5M | ||
Free Cash Flow | $408.0M | ||
EBIT | $214.7M | ||
EBITDA | $450.8M | ||
Net Working Capital | $3.4B | ||
EPS | $0.66 | ||
Enterprise Value/EBITDA | 88 | ||
Enterprise Value/Revenue | 21 | ||
P/B | 2 | ||
P/E | 338 | ||
PEG | -5 | ||
Price/Free Cash Flow | 81 | ||
Price/Operating Cash Flow | 73 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue